Parkwood Increases Position in Carmax (KMX); Carmignac Gestion Has Increased Chemocentryx (CCXI) Position by $3.30 Million; Market Value Declined – The DMinute

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Carmignac Gestion increased its stake in Chemocentryx Inc (CCXI) by 26.83% based on its latest 2018Q3 regulatory filing with the SEC. Carmignac Gestion bought 275,273 shares as the company’s stock declined 9.75% with the market. The institutional investor held 1.30M shares of the health care company at the end of 2018Q3, valued at $16.45 million, up from 1.03M at the end of the previous reported quarter. Carmignac Gestion who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $627.02M market cap company. The stock increased 4.46% or $0.53 during the last trading session, reaching $12.41. About 131,302 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 69.59% since January 10, 2018 and is uptrending. It has outperformed by 69.59% the S&P500. Some Historical CCXI News: 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19

Parkwood Llc increased its stake in Carmax Inc (KMX) by 29.54% based on its latest 2018Q3 regulatory filing with the SEC. Parkwood Llc bought 23,531 shares as the company’s stock declined 22.02% with the market. The institutional investor held 103,194 shares of the automotive aftermarket company at the end of 2018Q3, valued at $7.71 million, up from 79,663 at the end of the previous reported quarter. Parkwood Llc who had been investing in Carmax Inc for a number of months, seems to be bullish on the $10.97B market cap company. The stock decreased 1.77% or $1.16 during the last trading session, reaching $64.48. About 871,638 shares traded. CarMax, Inc. (NYSE:KMX) has declined 6.91% since January 10, 2018 and is downtrending. It has underperformed by 6.91% the S&P500. Some Historical KMX News: 25/04/2018 – Fitch Rates CarMax Auto Owner Trust 2018-2; 09/04/2018 – CARMAX MINING – WILL ACQUIRE ADDITIONAL MINERAL TENURES LOCATED CONTIGUOUS TO 100% OWNED EAGLEHEAD POLYMETALLIC PORPHYRY COPPER PROJECT; 09/04/2018 – Carmax Increases Size of Eaglehead Project; 04/04/2018 – CARMAX INC – CURRENTLY PLAN TO OPEN 15 STORES IN FISCAL 2019 AND BETWEEN 13 AND 16 STORES IN FISCAL 2020; 15/05/2018 – Highbridge Adds PepsiCo, Exits CarMax, Cuts Alibaba: 13F; 02/04/2018 – Carmax Inc expected to post earnings of 87 cents a share – Earnings Preview; 25/04/2018 – S&PGR Assigns CarMax Auto Owner Trust 2018-2 Notes Ratings; 04/04/2018 – CarMax 4Q Net $122.1M; 01/05/2018 – Thornburg Value Adds CarMax, Cuts Citigroup; 29/03/2018 Fitch Affirms CarMax Auto Owner Trust 2016-3 and 2017-2

Among 18 analysts covering Carmax Inc (NYSE:KMX), 9 have Buy rating, 1 Sell and 8 Hold. Therefore 50% are positive. Carmax Inc had 73 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was downgraded by Oppenheimer to “Perform” on Thursday, October 5. Wedbush maintained the stock with “Neutral” rating in Thursday, August 18 report. On Thursday, September 27 the stock rating was upgraded by Robert W. Baird to “Outperform”. The rating was maintained by Robert W. Baird with “Neutral” on Monday, June 25. Oppenheimer maintained it with “Buy” rating and $88.0 target in Wednesday, February 7 report. Oppenheimer maintained CarMax, Inc. (NYSE:KMX) on Friday, July 21 with “Buy” rating. The rating was downgraded by Morgan Stanley to “Underweight” on Wednesday, February 1. On Friday, August 25 the stock rating was maintained by Oppenheimer with “Buy”. The firm has “Sector Perform” rating given on Friday, April 7 by RBC Capital Markets. RBC Capital Markets maintained CarMax, Inc. (NYSE:KMX) rating on Friday, September 22. RBC Capital Markets has “Buy” rating and $83.0 target.

Since July 16, 2018, it had 0 insider buys, and 5 sales for $12.45 million activity. On Monday, October 29 the insider Daniels Jon G sold $1.16M. $2.90M worth of stock was sold by FOLLIARD THOMAS J on Wednesday, July 18. The insider Newberry Darren C sold 1,831 shares worth $135,128. The insider Shamim Mohammad sold 34,142 shares worth $2.53M.

Investors sentiment decreased to 0.88 in Q3 2018. Its down 0.15, from 1.03 in 2018Q2. It is negative, as 33 investors sold KMX shares while 164 reduced holdings. 50 funds opened positions while 123 raised stakes. 161.14 million shares or 2.35% less from 165.02 million shares in 2018Q2 were reported. Jefferies Gru Inc Ltd Company reported 52,708 shares or 0.03% of all its holdings. Benjamin F Edwards & Company holds 0% or 325 shares in its portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta has invested 0.03% in CarMax, Inc. (NYSE:KMX). 2,886 were reported by Ibm Retirement Fund. Engineers Gate Manager Ltd Partnership holds 12,647 shares. Vision has invested 0.75% in CarMax, Inc. (NYSE:KMX). Selz Lc holds 0.25% or 15,000 shares. Mason Street Advisors Limited Liability Corporation has 0.04% invested in CarMax, Inc. (NYSE:KMX). Livingston Asset Mngmt (Operating As Southport Management) reported 0.05% of its portfolio in CarMax, Inc. (NYSE:KMX). The Pennsylvania-based Cordasco Fincl Networks has invested 0.01% in CarMax, Inc. (NYSE:KMX). Wilbanks Smith Thomas Asset Mgmt Ltd Limited Liability Company reported 0.03% of its portfolio in CarMax, Inc. (NYSE:KMX). The Illinois-based Graybill Bartz And Assocs has invested 1.9% in CarMax, Inc. (NYSE:KMX). Capstone Invest Advisors Limited Liability holds 0% or 206 shares. Franklin Resource Incorporated accumulated 2,691 shares. Hutchinson Mngmt Ca owns 104,314 shares for 2.17% of their portfolio.

Parkwood Llc, which manages about $589.94M US Long portfolio, decreased its stake in Enbridge Energy Management L (NYSE:EEQ) by 45,277 shares to 12,053 shares, valued at $132,000 in 2018Q3, according to the filing. It also reduced its holding in Johnson & Johnson (NYSE:JNJ) by 23,576 shares in the quarter, leaving it with 40,689 shares, and cut its stake in Vanguard Ftse Emerging Marke (VWO).

More news for CarMax, Inc. (NYSE:KMX) were recently published by: Seekingalpha.com, which released: “More on CarMax Group Q3 results – Seeking Alpha” on December 21, 2018. Fool.com‘s article titled: “What CarMax Wants You to Know – The Motley Fool” and published on December 26, 2018 is yet another important article.

Among 8 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. ChemoCentryx had 12 analyst reports since September 3, 2015 according to SRatingsIntel. The firm earned “Mkt Outperform” rating on Tuesday, February 21 by JMP Securities. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) earned “Sell” rating by Zacks on Thursday, September 3. On Monday, September 21 the stock rating was downgraded by Zacks to “Sell”. The company was maintained on Tuesday, August 8 by Cowen & Co. The rating was downgraded by JP Morgan to “Neutral” on Tuesday, August 14. JMP Securities maintained the shares of CCXI in report on Thursday, August 10 with “Buy” rating. Canaccord Genuity maintained ChemoCentryx, Inc. (NASDAQ:CCXI) rating on Monday, November 12. Canaccord Genuity has “Buy” rating and $20 target. JP Morgan maintained it with “Overweight” rating and $16 target in Tuesday, March 13 report.

Investors sentiment decreased to 0.98 in 2018 Q3. Its down 0.61, from 1.59 in 2018Q2. It turned negative, as 14 investors sold CCXI shares while 29 reduced holdings. 13 funds opened positions while 29 raised stakes. 26.80 million shares or 1.64% more from 26.37 million shares in 2018Q2 were reported. D E Shaw Communication owns 259,837 shares or 0% of their US portfolio. Rhumbline Advisers holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 21,117 shares. Jpmorgan Chase & invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Qs Investors holds 643 shares or 0% of its portfolio. Blackrock holds 2.80M shares. Moreover, Dekabank Deutsche Girozentrale has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). California State Teachers Retirement System holds 34,380 shares. Element Mgmt Limited Liability has invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Ameritas Inv Ptnrs holds 0% or 2,120 shares. Financial Bank Of Montreal Can stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Adams Diversified Equity Fund holds 40,200 shares or 0.03% of its portfolio. 494,984 were accumulated by State Street. Sei Invests Com accumulated 67,062 shares or 0% of the stock. Los Angeles Cap Management And Equity Rech Inc holds 0% or 23,932 shares. Morgan Stanley reported 48,745 shares.

Since October 16, 2018, it had 0 insider buys, and 5 selling transactions for $86.67 million activity. $86,554 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) was sold by Schall Thomas J. on Wednesday, November 7. GLAXOSMITHKLINE PLC had sold 7.34 million shares worth $85.85 million on Tuesday, October 16.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx, Inc. (CCXI) CEO Dr. Thomas Schall on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” on August 09, 2018, also Globenewswire.com with their article: “ChemoCentryx Announces Proposed Public Offering of Common Stock – GlobeNewswire” published on September 26, 2018, Globenewswire.com published: “ChemoCentryx to Present at Two Upcoming Investor Conferences – GlobeNewswire” on May 30, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx Looks Like An Attractive Investment – Seeking Alpha” published on November 22, 2017 as well as Streetinsider.com‘s news article titled: “Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018 – StreetInsider.com” with publication date: November 14, 2018.

CarMax, Inc. (NYSE:KMX) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *